Cancer Blog
- Dr. Robert Nagourney -

Patients never have a second chance to receive first-line therapy, yet first-line therapy offers the best chance of durable remission.  

Biliary tract cancer afflicts 8,000 patients in the US each year. It is separated into intrahepatic and and extrahepatic.

Treatments should really be given more selectively, i.e. “give this chemotherapy only to those people who will benefit from it,” She said.

One of the critical advantages of Functional Profiling over traditional genomic testing is its focus on the actual response of cancer cells.